1-175330098-T-G
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBS1BS2
The NM_003285.3(TNR):āc.3769A>Cā(p.Ile1257Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000162 in 1,602,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_003285.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TNR | NM_003285.3 | c.3769A>C | p.Ile1257Leu | missense_variant | 21/23 | ENST00000367674.7 | |
LOC105371623 | XR_001738299.2 | n.318+588T>G | intron_variant, non_coding_transcript_variant | ||||
TNR | NM_001328635.2 | c.2770A>C | p.Ile924Leu | missense_variant | 21/23 | ||
LOC105371623 | XR_001738302.2 | n.232-3224T>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TNR | ENST00000367674.7 | c.3769A>C | p.Ile1257Leu | missense_variant | 21/23 | 5 | NM_003285.3 | P1 | |
ENST00000569593.1 | n.336-279T>G | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152236Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000321 AC: 8AN: 249322Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134726
GnomAD4 exome AF: 0.0000166 AC: 24AN: 1450088Hom.: 0 Cov.: 29 AF XY: 0.0000167 AC XY: 12AN XY: 719014
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152236Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74376
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 17, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at